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Many of the existing three-dimensional (3D) cancer models in vitro fail to represent the entire 
complex tumor microenvironment composed of cells and extra cellular matrix (ECM) and do not 
allow a reliable study of the tumoral features and progression. In this paper we reported a strategy to 
produce 3D in vitro microtissues of pancreatic ductal adenocarcinoma (PDAC) for studying the 
desmoplastic reaction activated by the stroma-cancer crosstalk. Human PDAC microtissues were 
obtained by co-culturing pancreatic cancer cells (PT45) and normal or cancer-associated fibroblasts 
within biodegradable microcarriers in a spinner flask bioreactor. Morphological and histological 
analyses highlighted that the presence of fibroblasts resulted in the deposition of a stromal matrix 
rich in collagen leading to the formation of tumor microtissues composed of a heterotypic cell 
population embedded in their own ECM. We analyzed the modulation of expression of ECM genes 
and proteins and found that when fibroblasts were co-cultured with PT45, they acquired a 
myofibroblast phenotype and expressed the desmoplastic reaction markers. This PDAC microtissue, 
closely recapitulating key PDAC microenvironment characteristics, provides a valuable tool to 
elucidate the complex stroma–cancer interrelationship and could be used in a future perspective as a 
testing platform for anticancer drugs in Tissue-on-chip technology. 
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Cells in their natural environment grow within an organized 3D matrix, which deeply influences 
physiological and pathological events occurring in the tissue. Tumors are often studied in vitro by 
means of extremely simplified 2D cell cultures or expensive and ethically problematic animal 
model systems [1,2]. The latter may not adequately reproduce some features of human tumors, in 
particular therapeutic responses and mechanisms sustaining drug resistance [3,4]. In this scenario 
3D tissue-engineered tumor models are emerging as the most promising tool to investigate in vitro 
tumor formation and evolution, as well as stroma-tumor cross-talk in order to identify new genetic 
drivers and therapeutic targets [5-12]. The most widely used 3D biomimetic cancer models are 
spheroids, because of their 3D architecture. They cannot, however, recapitulate all features of solid 
tumors, since they lack the interactions with the ECM that plays a key-role in tumor progression 
and chemoresistance [13]. To overcome such limitations, many groups tried to incorporate a 
cancer–stromal cell mix (usually fibroblasts) into a 3D matrix, such as matrigel or collagen type I, 
to recreate the complex tissue architecture seen in vivo. In our understanding, they only provide an 
exogenous matrix in which the tumor cells are not enabled to establish the physiological cell-cell 
and cell-ECM interactions normally experienced in vivo. Moreover, these scaffolds often suffer 
from batch-to-batch variations and their performance is impaired by an incomplete understanding of 
their impact on cell behavior [4, 14-16]. PDAC is one of the most aggressive cancers and is the 
fourth leading cause of cancer death worldwide. It is specifically characterized by a desmoplastic 
reaction, a process in which fibrous tissue infiltrates into and envelops the cellular compartments, 
including cancer and stroma cells (endothelial cells, immune and endocrine cells, fibroblasts and 
stellate cells) [17-20]. Desmoplastic reaction is associated with accelerate proliferation of 
myofibroblasts, differentiated cells deriving from mesenchymal or stellate cells [21,22] and it is 
characterized by the up-regulation of matricellular components such as versican, periostin, 
fibronectin and hyaluronic acid [21,23]. Moreover, the invasiveness of PDAC is due to the continue 
cross-talk between fibroblasts and cancer cells [24]. Tumor cells drive differentiation of fibroblasts 
or mesenchymal stem cells into highly contractile and matrix-depositing myofibroblasts, expressing 
α-SMA, Vimentin and PDGFrβ, thereby promoting enhanced ECM assembly, alignment, 
unfolding, and cross-linking of collagen type I- and fibronectin-rich matrices [2]. Furthermore, the 
aberrant fibrotic reaction compresses vessels thus limiting perfusion with consequent poor drug 
delivery [25,26]. The complexity of the pancreatic tumor microenvironment makes hard to study 
the development of this form of cancer; in particular, little is known about the mechanism involving 
pancreatic cancer cells and stroma [27]. Since recent studies have reported that the direct physical 




is an urgent need of realistic models able to recapitulate such a situation in vitro. In our survey we 
adapted already established tissue engineering strategies to obtain dermal microtissues to the need 
of producing pathological microunits [29]. We succeeded in fabricating a novel 3D in vitro 
microtissue of human PDAC by co-culturing PT45 cell line carrying mutated KRAS [30-33] and 
human normal or cancer-associated fibroblasts within biodegradable gelatin microcarriers in a 
spinner flask bioreactor. First, we produced homotypic culture of normal and tumoral stroma 
microtissues and assessed the difference in terms of gene expression, matrix deposition and cell 
growth between the two models. Then we investigated the interaction between stroma and 
pancreatic cancer cells analyzing ECM proteins and the genes modulated between homotypic and 
heterotypic models. The produced PDAC microtissues resulted in a complex biological system in 
which cells were embedded in their own ECM experiencing physiological cell-cell and cell-ECM 
interactions. These features strongly distinguish the proposed model from a mere 3D cell aggregate 
highlighting new insights in the fundamental regulatory role of the ECM in tumor progression. At 
last, these tumor microtissues could provide a new tool for the characterization of disease 
progression and drug resistance mechanisms in vitro. Moreover due to their size at a millimetric 
scale, they could be easily inserted in microfluidic devices for tissue-on-chip applications [34]. 
2. Materials and Methods 
2.1 3D tumor microtissue formation 
2.1.1 Microscaffold production  
Gelatin porous microbeads (GPMs) were prepared according to a modified double emulsion 
protocol (O/W/O) [35]. GPMs were stabilized by crosslink reaction with GPMs glyceraldehyde 
(GAL), in order to make them stable in aqueous environment at 37 °C, finally they were sterilized 
in absolute ethanol and washed in PBS as previously described [29].  
Briefly, Gelatin porous microbeads (GPMs) have been prepared according to a modified double 
emulsion technique (O/W/O). Gelatin (type B Sigma Aldrich Chemical Company, Bloom 
225,Mw¼176,654 Da) was dissolved into 10 ml of water containing TWEEN 85 (6% w/v) (Sigma 
Aldrich Chemical Company). The solution was kept at 40°C. Toluene containing SPAN 85 (3% 
w/v) (Sigma Aldrich Chemical Company) was continuously added to the aqueous gelatin solution 
(8% w/v) to obtain primary oil in water emulsion. The added toluene formed droplets in the gelatin 
solution until saturation. Beads of gelatin containing droplets of toluene were produced through the 
addition of excess toluene (30 ml) that allowed for a double emulsion (O/W/O). After cooling 
below 5°C, 20 ml of ethanol were added to extract toluene and stabilize GPMs. The resulting 
microspheres were filtered and washed with acetone and then dried at room temperature. 




Germany). GPMs with 75 ÷150 µm size range were recovered and further processed. GPMs have 
been stabilized by means of chemical treatment with 5% glyceraldehyde (GAL), in order to make 
them stable in aqueous environment at body temperature. In particular, GPMs were dispersed into 
an acetone/water solution containing different amounts of GAL and mixed at 4°C for 24 h. Then 
microspheres were filtered and washed with acetone and dried at room temperature. GPMs have 
spherical shape, the mean internal pore size is 10–20 µm and histological sections [29] of 
microtissues show that pore are well interconnected to allow the seeding and spreading of the cells 
throughout the scaffold. 
 
2.1.2 Cell-type 
Human normal fibroblasts (NF) and cancer associated fibroblast (CAF), kindly donated by 
Kojima’s group [36], were cultivated in high glucose DMEM with GlutaMAX (ThermoFisher), 
supplemented with 10% heat inactivated and fetal bovine serum, and 100 U/ml 
penicillin/streptomycin. PDAC cells (PT45) [29-32] were kindly donated by Dr. P. Allavena 
(Humanitas, Milano, I) and sub-cultured in RPMI-1640 medium (Sigma) supplemented with 10% 
heat inactivated fetal bovine serum, 100 µg/ml L-glutamine, 100 U/ml penicillin/streptomycin. 
Cells were maintained at 37 °C in humidified atmosphere containing 5% CO2. For 2D co-cultures 
experiments cells were mixed in suspension 1:3 (PT45/NF or PT45/CAF) ratio and plated at a 
density of 3000 cell/cm2.  
2.1.3 Lentivirus production and cell infection 
Virus was produced in HEK-293T cells calcium phosphate transfected (kit Promega) with pLVX-
DsRed-Express2-N1 or pLVX-ZsGreen1-N1 vectors (Clontech, USA). Supernatant was collected at 
48 and 72 h post transfection and filtered through a 0.4-µm Nalgene filtration unit. Lentiviral 
particles supernatants were concentrated by ultracentrifugation at 19.500 g for 2 h at 20 °C. The 
viral titer was determined by transducing Hela cells with serial dilutions of virus. Stromal NF and 
CAF cells were infected with pLVX-DsRed-Express2-N1 (Red) while PT45 tumor cells with 
pLVX-ZsGreen1-N1 (Green). Selection was achieved by a 24 h incubation with puromycin (2 
µg/ml).  
2.1.4 Homotypic cell culture  
All cell cultures on microscaffolds were performed in a spinner flask (100 ml Cellspin, Integra) by 
following a previously established procedure [29]. For the homotypic culture (NF, CAF and PT45 
alone) 50 mg of GPMs were loaded together with 7.5*105 cells (30cell/GMP ratio). To promote cell 
seeding on GMPs an intermittent stirring regime (30 min at 0 rpm, 5 min at 30 rpm) for 6 h was 




free cells from the inoculated spinner cultures was calculated as [(C0 - Ct)*100]/C0 where C0 is the 
concentration of the cells at the inoculum time and Ct the concentration of the cells in the culture 
medium. Then, dynamic cultures were kept under continuous stirring at 30 rpm for up to 12 d. 
Medium was changed on the first day and every 3 days until the end of the experiments. From the 
second day of dynamic culture, 50 µg/ml of ascorbic acid were added. Microtissues (µTP) samples 
were taken for further investigations at days 1, 4, 8 and 12 for homotypic cultures and fixed. At the 
same days of culture, 1 ml aliquots were collected for cell growth monitoring on the GPM. Briefly, 
200 µl of the same aliquots were transferred to a cell culture dish (w/2 mm grid Nunc) for 
microcarrier counting, after which the microcarrier suspension was placed in a new 2 ml tube and 
washed twice with PBS. To detach cells from microcarriers, µTP were digested by collagenase A 
(Roche Life sciences, Italy) 60 min at 37 °C, centrifuged 5 min at 2000 rpm and incubated 5 min in 
Trypsin (Lonza, Italy). The detached cells were then counted using a hemocytometer. Over the 
entire dynamic cell culture period in spinner flask, 500 µl aliquots were collected at days 1, 4, 8 and 
12 for cell distribution monitoring during µTP assembling. Confocal Leica TCS SP5 II combined 
with a Multiphoton Microscope where the NIR femtosecond laser beam was derived from a tunable 
compact mode-locked titanium:sapphire laser (Chamaleon Compact OPO-Vis, Coherent) was used. 
All the cells were stable transfected so they were monitored “live” without fixing procedure, on the 
day of the experiment. 
2.1.5 Heterotypic cell culture 
For heterotypic cultures, PT45 were added in the spinner flask at day 6 of the homotypic culture of 
NF or CAF (Fig.1). According to previous works [37,38] and supported by pilot experiments in 
which we tried various cancer cell/fibroblasts ratio (1:1; 1:2 and 1:3, data not shown), we found that 
the 1:3 ratio was the most suitable for our purpose because it allows fibroblasts to grow and 
produced ECM. The number of PT45 was stabilized in order to guarantee a ratio of PT45 to stromal 
cells equal to 1:3. µTP samples were taken for assay at days 1, 4, 6, 7 and 12 for heterotypic 
cultures. Cell counting was performed at day 1, 4, 6 (when pancreatic cells were added), 7 and 12 
for heterotypic cultures. For co-cultures, samples were observed at day 4, 6, 7, and 12 at confocal 
microscope to monitor µTP morphology.  
2.2 Tumor microtissue characterization 
2.2.1 Gelatin zymography  
Gelatin zymography was performed for both NF-µTP and CAF-µTP culture surnatants as follows: 
gel (SDS–PAGE, 10%) was copolymerized with gelatin (0.1%) (Sigma-Aldrich). Electrophoresis 
was carried out using the minigel lab apparatus Mini Protean 3 (Biorad) at a constant voltage of 




renaturation buffer (2.5% Triton X-100 in 50 mM Tris–HCl, pH 7.5) for 1 h in an orbital shaker. 
Then the gel was incubated for 18 h at 37 °C in incubation buffer (0.15 M NaCl, 10 mM CaCl2, 
0.02% NaN3 in 50 mM Tris–HCl pH 7.5). Gel was then stained with Coomassie blue and destained 
with 30% methanol and 10% acetic acid. Areas of enzymatic activity appeared as clear bands over 
the dark background. Following zymography, the degree of gelatin digestion was quantified using 
Image J software and the image was digitally inverted, so that the integration of bands was reported 
as positive values. We reported the pixel intensity of the area of each gelatin-digested band. 
2.2.2 Areas analysis 
For area analysis, 1 ml of µTP homotypic culture at day 4, 8 and 12 on a 35 mm Petri dish were 
observed with a light microscope (Olympus, BX53). Twenty images were taken at the same 
magnification for each sample at every time-point. Area was calculated using Image J software. 
Briefly, scanned color image was converted to an 8-bit grayscale format; hence, measurement scale 
was set and automated threshold included only dark areas. At last, particles were analyzed and the 
area was calculated.  
2.2.3 Collagen fraction and GLCM texture analysis 
Two-photon excited fluorescence was used to induce second harmonic generation (SHG) and obtain 
high-resolution images of unstained collagen structures in µTP’s ECM. Hence, the samples were 
observed exploiting the different fluorescence from the lentiviral vector used as described before 
(pLVX -DsRed-express2-N1 with λex=554nm, λem=591nm; pLVX-ZsGreen1-N1 λex=493nm, λem 
=505nm) as well as to induce second harmonic generation (SHG) (λ=840 nm). Homotypic and 
heterotypic µTP samples were used for SHG analysis by using ImageJ® software. In order to 
quantify the collagen fraction in the endogenous ECM, the ROI were chosen by excluding the 
signal rising from the microbeads. The collagen portion in the ECM space was represented by the 
bright pixels (Nc) in grayscale rising from the SHG signal, while the non-collagen portion appeared 
as black pixels (Nb). We define collagen fraction (CF) as the ratio between bright pixels to total 
pixels in the selected ROI. We also correlated this ratio to the cell number in the ROI, counting the 
nuclei [39]. Moreover, to quantitatively assess the collagen-related changes in the architecture we 
performed Grey-Level Co-occurrence Matrix (GLCM) texture analysis, using the ImageJ plug-in 
“Texture” on SHG images, according to the procedure previously described [40].  
2.2.4 Histological and immunohistochemical analysis 
One ml of µTP suspension was formalin-fixed and paraffin embedded. Successively, the samples 
were sectioned at a thickness of 7 µm. Masson’s trichrome (Sigma Aldrich) and Alcian Blue 
(Bioptica) stainings were performed according to standard protocols. At last, the sections were 




features of µTP were observed with a light microscope (Olympus, BX53). The images obtained 
were processed by means of ImageJ® software. For Masson’s trichrome and Alcian Blue staining, 
we consider the Blue staining, indicative of ECM and glycosaminoglycans deposition, that 
was separated from other colours by manual thresholding of hue (121-179), saturation (20-255), and 
brightness (10-255) values. Then, the ECM deposition was quantified as mean percentage of blue 
staining area. Ten sections were used and at least five different fields were randomly 
examined in each section for each time point. For immunohistochemical staining (IHC) of anti-
human Ki-67, α-SMA, Vimentin and PDGFβ-r (Abcam,UK). A mouse and rabbit specific 
HRP/DAB (ABC) detection kit (Abcam, UK) was used according to the manufacturer’s protocol. 
2.2.5 Immunofluorescence analysis 
Samples from 1 ml of µTP suspension were frozen in OCT compound and cut into 10-µm thick 
sections after overnight treatment at 4 °C in a 30% sucrose solution. Tissue slices were fixed in 4% 
paraformaldehyde for 10 min at room temperature. The antibodies used for tissue 
immunofluorescence (IF) staining were as follows: anti-α-SMA (Sigma); anti-POSTN and anti-
Versican (Abcam). The sections were then incubated with the appropriate fluorescence-conjugated 
secondary antibodies (Alexa 647 or 488, Life Technologies), and nuclei were counterstained with 
DAPI (Life Technologies). The samples were mounted using fluorescent mounting medium (Dako). 
All immunofluorescence images were captured and analyzed using a Leica SPEII confocal laser-
scanning microscope (Leica Microsystems). Image acquisition was performed maintaining the same 
laser power, gain and offset settings. Multiple independent fields (10-15 for every sections; 40X 
magnification) were randomly chosen and analyzed. Image quantification was performed using NIH 
ImageJ and expressed as the percentage of the fluorescence area relative to the protein signal 
respect to the whole image’s area. 
2.3 Gene expression analysis 
2.3.1 Fluorescence-Activated Cell Sorting Analysis  
Single-cell suspensions of 3D co-culture µTP or corresponding 2D co-cultures were prepared as 
follows: µTP or cells were digested in StemPro Accutase (Thermofisher). Enzymatic digestion was 
incubated at 37 °C for 15-20 min prior to the substrate being passed through a 70-µm cell strainer. 
The resulting cell suspension was washed and centrifuged at 1200 RPM for 5 min and re-suspended 
in MACS buffer with DAPI (Life Technologies). To exclude dead cells, DAPI was added 
immediately prior to sorting. The purity of DsRed+ (NF and CAF) and ZsGreen+ (PT45) cells was 
assessed  by flow cytometry Cyan ADP Analyzer (Beckman Counter) and was above 90%. DsRed+ 
(NF and CAF) and ZsGreen+ (PT45) cells were sorted by fluorescence-activated cell sorting 




acquired and analyzed using Summit v5.2 software (Beckman Coulter, Inc., Fullerton, CA, USA). 
The sorted cells were immediately stored in Qiazol Lysis reagent (Qiagen).  
2.3.2 RNA extraction and quantitative Real Time PCR  
Total RNA was extracted from tumors using an RNeasy mini kit (Qiagen). For cDNA synthesis, a 
High Capacity cDNA Reverse Transcription kit (Life Technologies) was used according to the 
manufacturer’s instructions. An RNA quality check, including concentration and purity, was 
performed with a Nanodrop ND-100 (Nanodrop Technologies). Quantitative real time PCR was 
performed on a CFX96 (Bio-Rad) using SYBR-green PCR MasterMix (Life Technologies). The 
PCR thermal profiles were 95 °C for 15 s and 60 °C for 60 s (40 cycles). All experiments were 
performed in triplicate. Melting curve analysis was performed for each PCR reaction to confirm the 
specificity of the amplifications. The housekeeping gene TBP was used to normalize the expression 
data. The primer sequences and product sizes are indicated in Table S1. 
2.3.3 Microarray-based transcriptional profiling and bioinformatics analysis of microarray 
data 
For gene expression profiling analysis, 300 ng of total RNA was amplified and labeled using an 
Illumina TotalPrep RNA Amplification Kit (Life Technologies). A total of 750 ng cRNA probes 
was hybridized on the HumanHT-12 v4.0 Expression Bead Chip (Illumina). All experiments were 
performed in biological triplicate (duplicate for 2D groups). Cubic spline-normalized probe 
intensity data, together with detection p-values, were obtained using the GenomeStudio software 
V2011.01 (Illumina). We selected for further analysis probes characterized by at least one 
experimental point having a detection p-value < 0.05. For each gene, we retained the associated 
probe with the largest mean expression value across all samples. The data were then log2 
transformed for all subsequent analyses. For each probe, the log2 signal in each sample was 
converted to the log2 ratio against the global average expression of that probe in all samples. The 
log2 ratio expression data were clustered and visualized using GEDAS software [41]. One-way 
ANOVA test and LIMMA [42] were used to identify the modulated genes. For the ANOVA test, p-
values were corrected for multiple testing using a Benjamini–Hochberg procedure [43], and a cutoff 
of 0.1 for the false discovery rate (FDR) was used to define differentially modulated genes across 
all four experimental conditions. In the LIMMA analysis, a threshold of | log2 FC | of 1 and 
adjusted p-value < 0.1 were used to select differentially expressed genes; for each pair-wise 
comparison, each of the treatments was compared separately to the control samples. All the 
statistical analyses were performed within the R environment (http://www.R-project.org/). GSEA 
was performed as described in [44], using the publicly available desktop application from the Broad 




filtering, for all the datasets, probes where collapsed on Gene Symbols, again selecting for each 
Gene the probe with the largest mean expression across all the experiments. The data were analyzed 
for enrichment in biological themes (GO – Biological Processes, Molecular Functions, Cellular 
Components) using the Database for Annotation, Visualization and Integrated Discovery 
Bioinformatics Resources (DAVID, http://david.abcc.ncifcrf.gov). GSEA Enrichment statistics 
were performed with the default setting, based on Pearson metric. P-values and FDRs were 
calculated by repeating sample permutations 1000 times. 3D microarray data have been deposited 
in The Gene Expression Omnibus of the National Center for Biotechnology Information (accession 
number GSE81850). 
2.4 Statistical analyses 
Data are expressed as mean ± SD. Differences between groups were determined using a one-way 
analysis of variance with Kruskal-Wallis test. Significance between groups was established for p < 
0.05. 
3. Results 
3.1 NF-µTP and CAF-µTP production by dynamic culture: analysis of dimension, ECM 
deposition and cell growth during culture time 
Before fabricating the heterotypic tumoral µTP, we investigated the behavior of normal fibroblasts 
(NF) and cancer-associated fibroblasts (CAF) in homotypic 3D cultures. As expected, CAF showed 
a higher level of α-SMA, a specific biomarker of fibroblast differentiation and activation,  than NF   
(Fig.S1a-b). In addition, qRT-PCR revealed an increased mRNA expression level in the CAF of 
both α-SMA (60-fold) and SDF-1 (33-fold), a cancer-specific cytokine, which has been 
demonstrated to be up-regulated in CAF compared to NF [36,45] (Fig. S1c). Therefore, NF and 
CAF were used to produce homotypic µTP by their growth on gelatin microscaffolds in a spinner 
bioreactor, as described in Fig. 1. NF and CAF proliferation was analyzed by counting the number 
of cells per microtissue at day 1, 4, 8 and 12. Cell number increased about 5 times along 12 days, 
with a final ratio of about 1000 cells/microtissue (cells/µTP) both for NF and CAF (Fig 2a). We 
analyzed the dimensional evolution of µTP by evaluating their area at 4, 8 and 12 days. We 
observed that NF-µTP did not show variations in the surface area during the 12 days of culture, 
while CAF-µTP tended to contract after four days, showing a smaller surface than NF-µTP area at 
day 12 (Fig 2b). By using NF and CAF carrying DsRed protein, the formation of NF- and CAF-µTP 
was monitored by confocal microscopy at day 4, 8 and 12 (Fig S1d-i), showing the homogeneous 
distribution of growing cells and their aggregation to form a stromal microtissue, also due to the 




expression of Ki-67 showed the distribution of the cells in active proliferation state in the stromal 
microtissue. Interestingly NFs were uniformly proliferating (Fig. 2c), while in CAF µTP cell 
growth was mainly observed at the periphery (Fig. 2d). We hypothesized that this different behavior 
could be justified by the different metabolism featuring CAF and NF. It is well known that CAFs 
have a faster metabolism [46] as consequence there are more cells in active proliferation state at the 
periphery of the microtissue to easily enter in contact with nutrients. The ECM of NF- and CAF-
µTP was further analyzed to detect the presence of collagenous and non-collagenous components. 
Masson’s trichrome staining highlighted a much stronger collagen deposition in the ECM of CAF-
µTP compared to NF-µTP (Fig 2e and 2f) and a corresponding more pronounced microscaffold 
degradation during culture time in the former compared to the latter (Fig. S2). Acid 
glycosaminoglycans stained by Alcian blue (Fig 2g,h) were more abundant in CAF-µTP than in 
NF-µTP. Of note PDAC desmoplastic reactions are enriched in these heteropolysaccarides [47]. 
Furthermore, the content of collagen and glycosaminoglycans (GAGs) was quantified and the 
results reported in the Fig. S3. Briefly, the content of collagen in CAF-µTP was higher than in NF-
µTP (31.8±1.4 % vs 21.6±0.9%) (Fig. S3a), as well as the GAGs deposition area was larger in 
CAF-µTP than in NF-µTP (51.1±2.3 % vs 23.7±1.02%) (Fig. S3b). 
3.2 NF-µTP and CAF-µTP over express ECM remodeling genes and down-regulate cell cycle 
gene compared to 2D culture 
To gain further insight into the 3D µTP, we examined the phenotypes of NF and CAF performing 
cDNA microarray analyses to find global gene expression changes in 3D versus 2D culture. Two to 
three replicates were prepared per group and genes whose levels differed significantly after 12 days 
of culture among 3D and 2D were identified. Volcano plots show the changes in the log2-fold 
change and p-values for all genes differentially expressed in the separate comparisons of NF-µTP 
and CAF-µTP with respect to the relative 2D cultures (Fig 3a). LIMMA analysis [48] revealed that 
NF-µTP had differential expression compared to the relative 2D cultures for 1845 probe sets (out of 
19.842), where a difference was defined as a fold change (log2) greater than 1 or less than -1 and a 
adjusted p-value less than 0.1 to achieve statistical and biological significance; among them, 1022 
genes were up-regulated and 823 genes down-regulated. CAF-µTP had differential expression 
compared to the relative 2D cultures for 456 probe sets (out of 17.849); 126 genes were up-
regulated and 331 genes down-regulated. A large number of genes differentially expressed in NF-
µTP relative to NF 2D cultures changed in a similar manner in CAF-µTP relative to CAF 2D 
cultures (Fig 3b). The prostaglandin-endoperoxide synthase 2 (PTGS2), the chemokine ligand 2 




(MMP1) were among the most up-regulated genes in both NF-µTP and CAF-µTP (Table S2). 
However, a much larger cohort of genes changed in expression in NF-µTP relative to NF 2D 
cultures than in CAF-µTP relative to CAF 2D cultures (Fig 3b; Table S2). DAVID and GSEA 
analyses were carried out on microarray data set to identify associated biological processes and 
pathways [44]. The gene sets with significantly different expression (FDR < 0.01, p < 0.05) were 
picked up.  Genes that were up-regulated in NF-µTP compared with the relative 2D cultures 
showed enrichment in the Gene Ontology (GO) categories related to ECM remodeling 
(“extracellular matrix”, “proteinaceous extracellular matrix”, “biological adhesion”, “cell 
adhesion”, “collagen”, “extracellular matrix”; Table 1), while genes down-regulated in NF-µTP 
were highly enriched in the gene set involved in cell cycle processes (“M phase”, “cell division”, 
“cell cycle phase”, “cell cycle”, “nuclear division”, “mitosis”, “M phase of mitotic cell”, “mitotic 
cell cycle”, “cell cycle process”; Table 1), suggesting that cells cultured in 2D proliferate more 
rapidly compared to cells cultured in 3D. In agreement, GSEA revealed enrichment of genes 
involved in ECM organization, and down-regulation of genes related to cell cycle process (Fig. 3c). 
Similar pathways were also found enriched (“proteinaceous extracellular matrix”, “extracellular 
matrix”, “biological adhesion”, “metallopeptidase activity”) or down-regulated (“cell cycle 
process”) in CAF-µTP relative to CAF 2D cultures (Fig. S4a, Table S3). Matrix remodeling is a 
complex series of events that involve cell secretory properties (e.g. deposition of collagen), as well 
as secretion of proteases (e.g. MMPs). GSEA analysis highlighted the enrichment also for the 
metallopeptidase activity, in particular we found the up-regulation of MMP2, MMP3, MMP9, 
MMP14 in NF and CAF cultured in 3D condition, suggesting their involvement in the degradation 
of gelatin microcarriers (Fig S4b). Changes in cell structure in response to the dimensionality show 
that observed differences in morphology and organization in tissue-like structures are influenced by 
the underlying transcriptional profile. These results suggest that the 3D culture system provides a 
model that better mimics cell-ECM interactions compared to the traditional 2D monolayer. 
Microarray analysis reported that in NF and CAF the genes with the largest fold changes relative to 
2D conditions belong to the family of the ECM components. Microarray results were confirmed by 
qRT-PCR for 9 genes related to ECM remodeling that were found up-regulated in NF-µTP and 
CAF-µTP compared to the relative 2D cultures. They include different collagens (COL6A1, 
COL16A1, COL18A1), matrix metallo-proteinases (MMP1, MMP2, MMP3, MMP14), IL8, and 
ITGA11 (Fig. 4a). At last, surnatants were analyzed by zymography to investigate the expression 
and secretion of MMPs (Fig 4b). We observed an over-expression of MMP2 and MMP9 in CAF-




NF-µTP (Fig. 2b). We hypothesized that the higher expression of MMPs correlates with a more 
marked of gelatin microscaffolds with consequent contraction of microtissues. 
3.3 Morphology and gene profile of homotypic PT45 spinner culture  
PT45 were grown on gelatin microcarriers, forming a homotypic microtissue (PT45-µTP), which 
showed clear difference in morphology compared to CAF-µTP and NF-µTP. Indeed, PT45-µTP 
were formed by single microscaffolds completely surrounded by PT45 that adhered layer by layer 
on the microcarrier surfaces and colonized their pores (Fig. 5a). In contrast to fibroblast 
microtissues, PT45-µTP did not show SHG signal at multiphoton microscopy, indicating the 
absence of structured collagen (Fig. 5a), as further inferred by Masson’s trichrome staining (Fig. 
5b). Moreover, immunohistochemical staining for Ki-67 protein demonstrated that PT45 cells were 
in proliferating phase (Fig. 5c). PT45 cell number in µTP was about 350 per bead after 12 days   
(Fig. 5d). PT45-µTP area was not modified  (Fig 5e), and these microtissues  did not  aggregate to 
form a larger structures comprising cells and ECM.  
Microarray analysis allowed us to identify 344 genes (out of 19.843), which were modulated in 
PT45-µTP compared with 2D cultures. Specifically 207 genes were up-regulated and 137 genes 
down-regulated (Fig. S5). The functional significance of these genes was assessed using DAVID 
and GSEA. Interestingly, as we reported for NF-µTP and CAF-µTP, GO terms belonging to the 
various categories of cell cycle processes (“cell cycle”, “cell cycle process”, “cell cycle phase”, “M 
phase”, “mitotic cell cycle”, “cell division”) were significantly represented in the down-regulated 
gene group (Fig 5f and Table2). Regarding the up-regulated genes group, we found that up-
regulated genes showed enrichment in the GO categories related to “extracellular region part”, 
“MHC class I receptor activity” and “antigen processing and presentation of peptide antigen via 
MHC class I” (Table 2). According to the lack of structured collagen (Fig 5a-b), DAVID and GSEA 
analyses did not show any significant enrichment in the functional categories related to ECM 
composition or ECM remodeling was revealed among the up-regulated genes. 
3.4 Development of 3D PDAC-µTP  
In order to closely mimic the in vivo conditions of PDAC, we developed a 3D heterotypic culture 
system that provided a microtissue model for studying the behaviors and the dynamic interaction 
between stroma and cancer cells. µTP were produced by adding PT45 on NF- or CAF-µTP at day 6 
of dynamic 3D culture, as reported in Figure 1. The heterotypic NF/PT45-µTP and CAF/PT45-µTP 
were investigated by evaluating cell proliferation, dimensional evolution, morphology and ECM 
composition. The number of NF and CAF reached the value of 5000 and 1000 cells/µTP, 




cells/µTP both in NF/PT45 and CAF/PT45-µTP (Fig 6a-b). Area analysis of heterotypic 
microtissues was performed at day 4, 8 and 12 of dynamic culture. As previously reported (Fig 2b), 
CAF-µTP were smaller than that of NF-µTP at earlier time points (day 4 and 8). However the 
addition of PT45 cells to NF-µTPs induced a contraction of the whole µTP (Fig. 6c). Therefore the 
areas of NF/PT45 and CAF/PT45-µTP were similar at day 8, suggesting that PT45 cells were able 
to differentiate NF to CAF, which are known to shrink ECM [49]. Matrix deposition was evaluated 
by Masson’s trichrome (Fig. 6d-e) and Alcian blue staining (Fig. 6f-g) showing compact and highly 
cellularized tissues, enriched in collagen and glycosaminoglycan deposition mainly localized in the 
inner part of the microtissues, corresponding to the stromal area. The phenomenon was evident both 
in CAF/PT45-µTP and NF/PT45-µTP demonstrating for the latter a desmoplastic reaction due to 
normal fibroblast activation in presence of pancreatic cancer cells. The expression of the 
proliferation markers Ki-67 was localized in the outer part of the µTPs, demonstrating that PT45 
cells were in active proliferation both in NF/PT45-µTP and CAF/PT45-µTP (Fig. 6h-i).  
The morphology of 3D microtissues and the distribution of fibroblasts and PT45 cells, respectively 
carrying DsRed and Zs-Green lentiviral vectors, were observed by confocal microscopy. The 
images (Fig. 6j and 6k) clearly show that PT45 were evenly localized throughout the µTP, 
interacting with NF or CAF, giving rise to a multicellular model of pancreatic cancer.  
3.5 Dynamic crosstalk in NF/PT45-µTP induces NF activation and the expression of PDAC 
desmoplastic markers 
To evaluate the functional cross-talk between stromal and cancer cells at gene level after 12 days, 
NF/PT45-µTP and CAF/PT45-µTP were dissociated and DsRed+ (NF and CAF) or ZSGreen+ 
(PT45) cells were FACS sorted (Fig. 7a). In NF/PT45-µTP we found the 53% of the cells were 
DsRed+ (NF) and the 46% ZsGreen+ (PT45). In CAF/PT45-µTP we found the 70%,  of the cells 
were DsRed+ (NF) and the 26% ZsGreen+ (PT45). After the isolation from the 3D co-cultures we 
analyzed the gene expression profile of NF, CAF and PT45 cells. We observed that there was only 
1 gene differentially expressed between NF and CAF isolated from NF/PT45-µTP and CAF/PT45-
µTP, suggesting the activation of NF when co-cultured with PT45 in 3D conditions. These 
observations were supported by the immunohistochemistry evaluation of α-SMA, PDGFβr and 
vimentin in NF-µTP and NF/PT45-µTP that confirmed the up-regulation of these fibroblast 
activation markers in NF co-cultured with PT45 (Fig. S6). 
Indeed, Venn diagram in Fig. 7b shows a larger number of genes differentially expressed between 
CAF and NF when cells are cultured in 2D (488 genes; 455 genes up-regulated and 33 down-




signature of NF isolated from NF/PT45-µTP by GSEA. Heatmap of the “extracellular matrix” gene 
set highlighted the up-regulated expression of a set of genes involved in the desmoplasia, a specific 
stromal reaction that has been associated with tumor progression and poor prognosis of PDAC [50]. 
In particular we observed the higher expression of COL1, COL3, MMP11, VCN, POSTN in NF 
isolated from NF/PT45-µTP compared to the other conditions (NF in 2D; NF harvested from 
NF/PT45 in 2D and NF from NF-µTP) (Fig. 7c). Similar results were obtained in CAF isolated 
from CAF/PT45-µTP (Fig. S7a). Microarray results were confirmed by qRT-PCR for 6 genes 
(COL3, COL4, COL5, MMP11, VCN, POSTN) related to desmoplasia that were found up-
regulated in NF isolated from NF/PT45-µTP compared to the other conditions (NF in 2D; NF 
harvested from NF/PT45 in 2D and NF from NF-µTP) (Fig. 7d). Versican (VCN) and periostin 
(POSTN) are among the genes of desmoplastic reaction that play a significant role in PDAC 
progression [51-55]. By immunofluorescence staining we found that the expression of VCN and 
POSTN were respectively ∼3 and 2 fold higher in NF/PT45-µTP than in NF-µTP (VCN+ % area, 
NF-µTP: 8.2 ± 3.84%; NF/PT45-µTP: 20.1 ± 2.62%; p < 0.001; POSTN+ % area, NF-µTP: 13.1 ± 
1.2%; NF/PT45-µTP: 25.9 ± 1.7%; p < 0.001) (Fig. 8a). Similar results were obtained in 
CAF/PT45-µTP when stained for VCN and POSTN (Fig. S7 b-c). Taken together, these results 
clearly demonstrate the activation of NF in the co-culture system developed through the assessing 
of the desmoplastic markers. In order to deeper investigate the collagen deposition in 3D µTP, 
second harmonic generation (SHG) imaging was performed for the homotypic and heterotypic 
models (Fig 8b-e). Moreover the collagen fraction was also quantified in the four models, 
highlighting a stronger secretion of collagen in µTP where fibroblasts show an activated phenotype 
(Fig. 8f). Finally, we also investigated the correlation index obtained by the analysis of the different 
SHG signal detected by the four 3D models (Fig. 8g). By performing GLCM texture analysis, we 
evaluated the correlation length as a parameter indicating the roughness of the collagen matrix that 
can be correlated to the tumor progression. The values of correlation length obtaining for the 
PDAC-µTP were higher in comparison to the normal homotypic NF-µTP, strengthened the 
hypothesis of the presence of fibrosis pathways in the activated microtissues. 
4. Discussion  
Most of the available models for cancer research still fail to mimic several important aspects of the 
tumor microenvironment, such as the presence of stroma cell populations and a complex ECM that 
guarantees crucial patho-physiological molecular cross-talks [2]. In this paper, we developed a 3D 
cancer model in which tumor cells interact with the endogenous ECM produced by fibroblasts in 




realistic testing platform for pre-clinical use. This provided a patho-physiological context, which 
more accurately replicated solid cancer microenvironment compared not only to monolayer cultures 
in 2D but also to 3D spheroids models [56-58]. Indeed the latter are often used to mimic tumor 
tissues, but they are usually composed of a single cell type and lacked an organized ECM. It is 
widely demonstrated that the crosstalk between tumor and stroma cells was made possible by the 
spatial architecture of the ECM where paracrine signals could be transmitted between the different 
cells [59]. However, the lack of a model sustaining 3D cell autonomous ECM formation is 
prejudicial to study the dynamical reciprocity between cells and extracellular space occurring in 
vivo during cancer formation and progression. PDAC is a paradigmatic example of the role of 
stromal component in dictating the progression diseases as well as the therapeutic approach to be 
followed. Actually PDAC is characterized by a prominent desmoplastic reaction, which compresses 
the vascular bed thus reducing drug delivery and recruitment of immune competent cells that could 
represent important targets in this cancer type [60]. The desmoplastic reaction is driven by 
quiescent pancreatic stellate cells, which are activated by cancer cells to acquire a myofibroblasts 
(or CAF) phenotype, expressing some markers as α-SMA and PDGFβr [61]. In our 3D tumor 
model, native ECM is present and can carry out its regulatory role in guiding cell activation and 
tissue formation. By using a co-culture system on gelatin porous microcarriers, PT45, a human 
PDAC cell line carrying mutated KRAS, TP53 and CDKN2 [62-65], and human fibroblasts exploit a 
scalable and reproducible method to prepare uniform 3D tumors. Along the dynamic culture, gelatin 
microcarriers are progressively digested by embedded cells, which autonomously produce ECM 
with the features of the desmoplastic reaction. The morphological, molecular and 
immunophenotypic analysis of homo- and heterotypic µTP demonstrated significant effects of the 
3D architecture combined with the features of different cell types on the µTP growth rate and on the 
cellular transcriptional profiles. Furthermore, the dynamic cell culture condition used allows a non-
invasive monitoring of culture progression and sampling for time-course studies in different 
conditions. Actually µTP constituted by fibroblasts alone grow and aggregate up to 350-400 µm in 
diameter, remodel the gelatin scaffold by depositing new ECM that undergo contraction. It is well-
known that activated fibroblasts sustain fibrotic response in tumor [66] and produce more ECM 
than normal fibroblasts: in our model these features are replicated by CAF-µTP. The different 
degradation rate of porous scaffolds could be correlated with over synthesis of MMPs by the 
activated stromal cells, leading to ECM remodeling that can facilitate metastasis dissemination [67]. 
On the contrary, the size of PT45-µTP does not increase along the dynamic culture as well as they 
do not form any aggregates, due to the lack of neo-synthetized ECM. As well, PT45 cells show poor 




cell µTP in remodeling ECM are supported by gene expression analysis, which does not show any 
significant modification of genes involved in fibrotic response in PT45-µTP compared with NF-
µTP and CAF-µTP. The most notable feature of heterotypic µTP is the appearance of the 
desmoplastic reaction, which occurs both with CAF and NF-µTP, indicating that in our model PT45 
are able to activate NF, as reported in vivo [68,69]. Transcriptional data show an up-regulation of 
the genes related to the ECM and desmoplastic reaction in NF/PT45-µTP in comparison to NF-
µTP, clearly indicating the phenotypic change occurring in NF during 3D co-culture. In particular, 
the fibroblast activation in NF/PT45-µTP is demonstrated by the over-expression of α-SMA and 
PDGFβr. The validation by qPCR and immunophenotypic staining of the microarray data in NF in 
homotypic and heterotypic cultures demonstrates the up-regulation of ECM-related genes, 
confirming that the heterotypic model fabricated is able to resemble both the genetic expression and 
the protein deposition that characterize the in vivo PDAC. Moreover, upon dissociation of 
heterotypic microtissues we found that cancer cells represented the predominant proportion of 
proliferating cells in agreement with other 3D co-cultured systems [70]. The morphology of 
NF/PT45-µTP and CAF/PT45-µTP are quite similar, demonstrating that -when co-cultured with 
PT45- both NF and CAF increase the deposition of endogenous matrix and glycosaminoglycans, 
mimicking the fibrotic microenvironment of pancreatic cancer [71]. Moreover the analysis based on 
SHG microscopy allows the quantification of ECM alteration that is routinely used to score 
collagen re-reorganization during tumoral progression in vivo [72-74]. The model we proposed is 
strengthened by the endogenous production and self-organization of ECM, leading to the presence 
of a more reliable dynamic interplay between cells and microenvironment. As a consequence, the 
correlation curve from GLCM analysis performed on unstained collagen network, led to the 
increase of the correlation length. This means that the collagen network we obtained in the PDAC 
model is quite similar to the architectural change due to stromal activation as happens in vivo in the 
case of pathological tissues [40,72-73]. This is a very important result, since so far no other in vitro 
tumor model allows to use this technique for analyzing ECM remodeling due to pathological events 
[74]. The observed ECM remodeling favors the invasion of the tumor cells into the µTP, mimicking 
the morphological features of PDAC, where myofibroblasts and cancer cells intimately connected 
to establish specific molecular cross-talks. Generally pancreatic CAFs release TGFβ, which triggers 
an invasive phenotype characterized by epithelial-mesenchymal, down-modulation E-cadherin, and 
up-regulation of the transcription factors Twist and Snail [75]. A common trait of 3D µTP is a 
reduced proliferative rate in comparison with 2D cultures, as previously described for other 3D 




in vivo, as a consequence of the restraints on energy availability within a solid structure [26]. As 
reported for homotypic µTP, gene expression analysis of the heterotypic culture of normal and 
CAFs with PT45 cells shows the down-regulation of the genes related to cell cycle, mitosis, cell 
division in 3D model in comparison to 2D cell culture, confirming a more physiological cells cycle 
in the 3D geometry. It is important to point out that the presence of the desmoplastic reaction that 
characterizes our heterotypic µTP has been previously demonstrated only when complex systems 
such as organoids from human PDAC were transplanted in recipient immune-compromised mice 
[77]. In conclusion, our results indicated that the established dynamic procedure allowed the 
development of PDAC µTP that mimic the capability of cancer cells to instruct stroma cells and 
reconstitute the desmoplastic reaction that characterizes the advanced stage of this neoplasia and 
affects drug delivery. 
 
Conclusion 
In the light of these considerations PDAC µTP can represent a valuable tool to approach the 
molecular dynamics between stroma and tumor cells and to test drugs interrupting this deleterious 
circuit. The substitution of gelatin scaffold with endogenous ECM makes our model a novel and 
unique tool to investigate the real signals passing between stroma and tumor cells. The results of 
this work have important implications in the advancement of tissue-on-chip technology furnishing 
reliable in vitro disease models in which the ECM can carry out its role of key regulator of cell and 
tissue functions. At last, the tissue engineering approach used to produce PDAC µTP could be 
applied to cell lines and patient-derived primary cultures in order to reproduce different kinds of 
cancer models.  
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Fig.1 Schematic representation of the process designed for developing the 3D in vitro PDAC 
model. Normal or cancer associated fibroblast were combined with gelatin microscaffold in a 
spinner bioreactor in order to generate stromal microtissues. After 6 days of dynamic culture, 
pancreatic cancer cells were added and the culture was stopped at day 12 for collecting PDAC 
microtissues in order to perform further investigations. 
 
Fig.2 Stromal µTP production and characterization. (a) Cell proliferation in homotypic 3D 
culture at day 1, 4, 8 and 12. (b) Dimensional analysis was performed calculating the area evolution 
of the stromal microtissues at day 4, 8 and 12. (c) Ki-67 IHC for NF and (d) CAF, scale bar is 50 
µm. Collagen deposition stained by Masson Trichrome in (d) NF- and (e) CAF-µTP. Detection of 
glycosaminoglycans by Alcian Blu staining: in (f) NF- and (g) CAF-µTP. Scale bar 50µm. 
Statistical significance, *p<0.05. All images are referred to µTP at day 12 of culture. 
 
Fig.3 Microarray analyses of NF- and CAF-µTP. (a) Volcano plots of gene expression showing 
fold-change and p-value of NF- and CAF-µTP versus their 2D cultures; up-regulated and down-
regulated genes are colored red and blue, respectively. (b) Venn diagram showing the overlapping 
subsets of differentially expressed genes (| log2  FC | > = 1, adjusted p-value < 0.1 in the NF- and 
CAF-µTP. (c) Enrichment plot relative to “extracellular matrix”, “metallopeptidase activity” and 
“cell cycle process” pathways for NF-µTP versus 2D culture, found enriched by GSEA analysis of 
microarray data. Normalized enrichment scores (NESs), p and q values are shown.  
 
Fig.4 ECM remodeling and MMPs secretion quantification. (a) qRT-PCR validation of 
significantly modulated genes in NF- and CAF-µTP;  n = 3. Error bars indicate SEMs. (b) MMPs 
secretion analyzed by zymography assay in NF- and CAF-µTP, at day 12 of dynamic culture.  
 
Fig.5 PT45-µTP production and characterization. (a) Confocal imaging of PT45-µTP, scale bar 
is 75 µm. (b) Masson Trichrome and (c) Ki-67 IHC staining of PT45-µTP, scale bar is 50 µm. All 
images are representative of day 12 of dynamic culture. (d) Cell proliferation and (e) area analysis 
of PT45-µTP at day 1, 4, 8, 12. (f) Enrichment plot relative to “cell cycle process” pathway for 
PT45-µTP versus 2D culture, found enriched by GSEA analysis of microarray data. Normalized 
enrichment scores (NESs), p and q values are shown. 
 
Fig.6 Characterization of PDAC-µTP. (a) Cell proliferation of NF/PT45-µTP and (b) CAF/PT45-
µTP at days 1, 6, 7, 9 and 12 of culture. (c) Area analysis for NF/PT45-µTP and CAF/PT45-µTP at 
days 1, 4, 8 and 12 of 3D co-culture. Masson Trichrome staining for (d) NF/PT45-µTP and (e) 
CAF/PT45-µTP. Alcian Blu staining for (f) NF/PT45-µTP and (g) CAF/PT45-µTP. Ki-67 IHC for 
(h) NF/PT45-µTP and (i) CAF/PT45-µTP, scale bar is 50 µm. Confocal imaging for (j) NF/PT45-
µTP and (k) CAF/PT45-µTP. Scale bar 75 µm. All images are referred to µTP at day 12 of culture. 
 
Fig.7 Gene expression profile, by microarray technique of PDAC-µTP. (a) Due to different 
infection of pancreatic and stromal cells, a cell sorting of co-cultured microtissues were performed 
before performing microarray. (b) Venn diagram showing the overlapping subsets of differentially 
expressed genes (| log2  FC | > = 1, adjusted p-value < 0.1). In clockwise direction: 2D culture of 
CAF versus 2D culture of NF, CAF from CAF-µTP versus NF-µTP, CAF from CAF/PT45-µTP 
versus NF from NF/PT45-µTP. (c) Heatmap of the GSEA “extracellular matrix” core gene set from 




expression changes in NF 2D, NF/PT45 2D, NF-µTP and NF/PT45-µTP; n = 3. Error bars indicate 
SEMs. 
 
Fig.8 Array validation by IF and SHG analysis of Collagen in µTP. (a) VCN (red staining) and 
POSTN (green staining) IF and relative quantification analysis on NF-µTP and NF/PT45-µTP; 
nuclei were stained by DAPI in blue and scale bar is 75 µm. All images are referred to µTP at day 
12 of culture. SHG signal (gray scale) from newly formed fibrillar collagen in NF-µTP (b), CAF-
µTP (c) and NF/PT45-µTP (d) and CAF/PT45-µTP (e). Scale bar = 75 µm. All images are referred 
to µTP at day 12 of culture. SHG signal quantification analysis as collagen fraction % (e) in 
homotypic and heterotypic fraction. Correlation curve (f) as a function of distance in µm in 
homotypic and heterotypic culture at day 12 of culture. Correlation length - λ – obtained by fitting 
parameters from normalized correlation curves in homotypic and heterotypic culture at day 12 of 
dynamic culture (g). Line and asterisks indicate statistical differences with p < 0.05.  
 
Table 1. Molecular pathways found enriched by DAVID analysis of microarray data. Up-
regulated and down-regulated GO terms of NF-µTP versus NF in 2D condition. 
 
Table 2. Molecular pathways found enriched by DAVID analysis of microarray data. Up-

















































Table 1. Molecular pathways found enriched by DAVID analysis of microarray data in 
NF 
Up-Regulated GO terms 





GO:0044421 extracellular region part 16,32 GO:0000279 M phase 13,33 
GO:0031012 extracellular matrix 9,51 GO:0051301 cell division 13,03 
GO:0005578 proteinaceous 
extracellular matrix 
9,22 GO:0022403 cell cycle phase 12,85 
GO:0044420 extracellular matrix part 8,51 GO:0007049 cell cycle 12,68 
GO:0005576 extracellular region 8,34 GO:0048285 organelle fission 12,40 
GO:0005615 extracellular space 7,58 GO:0000280 nuclear division 12,33 
GO:0009611 response to wounding 5,64 GO:0007067 mitosis 12,33 
GO:0022610 biological adhesion 5,51 GO:0000087 M phase of mitotic cell cycle 12,16 
GO:0007155 cell adhesion 5,22 GO:0000278 mitotic cell cycle 10,71 
GO:0042127 regulation of cell 
proliferation 
5,02 GO:0022402 cell cycle process 10,67 










GO:0042981 regulation of apoptosis 4,32 
GO:0000775 chromosome, centromeric 
region 
6,43 
GO:0030334 regulation of cell 
migration 


























Table 2. Molecular pathways found enriched by DAVID analysis of microarray data in PT45 
Up-Regulated gene family  -log10 (pvalue) 
GO:0005576 extracellular region 4,53 
GO:0032393 MHC class I receptor activity 3,81 
GO:0002474 antigen processing and presentation of peptide antigen via MHC class I 3,14 
GO:0042612 MHC class I protein complex 2,94 
GO:0048002 antigen processing and presentation of peptide antigen 2,28 
Down-regulated gene family  -log10 (pvalue) 
GO:0007049 cell cycle 4,21 
GO:0022402 cell cycle process 3,82 
GO:0022403 cell cycle phase 2,75 
GO:0000279 M phase 2,49 
GO:0006563 L-serine metabolic process 2,40 
GO:0000278 mitotic cell cycle 2,17 
GO:0009070 serine family amino acid biosynthetic process 2,12 
GO:0016053 organic acid biosynthetic process 1,99 
GO:0046394 carboxylic acid biosynthetic process 1,99 
GO:0016126 sterol biosynthetic process 1,96 
GO:0006564 L-serine biosynthetic process 1,90 
GO:0051301 cell division 1,75 
GO:0000775 chromosome, centromeric region 1,71 














Statement of significance 
Tumor microenvironment is extremely complex and its organization is due to the interaction 
between different kind of cells and the extracellular matrix. Tissue engineering could give the 
answer to the increasing need of 3D culture model that better recapitulate the tumor features at 
cellular and extracellular level. We aimed in this work at developing a microtissue tumor model by 
mean of seeding together cancer cells and fibroblasts on gelatin microsphere in order to monitor the 
crosstalk between the two cell populations and the endogenous extracellular matrix deposition. 
Results are of particular interest because of the need of heterotypic cancer model that can replicate 
the complexity of the tumor microenvironment and could be used as drug screening platform.  
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